Steven Simoens
Impact in
- Economics and Econometrics top 0.2%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 149
- Pharmaceutical Economics and Policy 139
- Immunology 71
- Biosimilars and Bioanalytical Methods 65
- Co-authors
- Isabelle Huys (88 shared papers)Arnold G. Vulto (59 shared papers)Pieter Dylst (20 shared papers)Minne Casteels (19 shared papers)Lone Hummelshøj (3 shared papers)Antonio Giuffrida (2 shared papers)David Cassiman (19 shared papers)Mélanie Bourassa Forcier (1 shared paper)
- Journals
- Frontiers in Pharmacology (36 papers)Value in Health (31 papers)Orphanet Journal of Rare Diseases (13 papers)Applied Health Economics and Health Policy (10 papers)BioDrugs (8 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Steven Simoens
397 papers receiving 8.5k citations
Steven Simoens's Hit Papers
Peers
Comparison fields: 5 of 181
- Economics and Econometrics 3.0k
- Geriatrics and Gerontology 324
- Immunology 1.5k
- Reproductive Medicine 502
- Applied Microbiology and Biotechnology 109
Countries citing papers authored by Steven Simoens
This map shows the geographic impact of Steven Simoens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Simoens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Simoens more than expected).
Fields of papers citing papers by Steven Simoens
This network shows the impact of papers produced by Steven Simoens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Simoens. The network helps show where Steven Simoens may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven Simoens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 412 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease Hit paper breakdown → | 2015 | 641 |
| 2 | 2014 | 271 | |
| 3 | 2007 | 269 | |
| 4 | 2004 | 253 | |
| 5 | 2011 | 196 | |
| 6 | 2012 | 125 | |
| 7 | 2008 | 123 | |
| 8 | 2020 | 111 | |
| 9 | 2006 | 110 | |
| 10 | 2018 | 102 | |
| 11 | 2017 | 95 | |
| 12 | 2008 | 94 | |
| 13 | 2013 | 94 | |
| 14 | 2019 | 93 | |
| 15 | 2018 | 90 | |
| 16 | 2010 | 85 | |
| 17 | 2015 | 85 | |
| 18 | 2011 | 85 | |
| 19 | 2009 | 82 | |
| 20 | 2013 | 82 |
About Steven Simoens
Steven Simoens is a scholar working on Economics and Econometrics, Immunology, Pediatrics, Perinatology and Child Health, General Health Professions and Public Health, Environmental and Occupational Health, having authored 412 papers that have together received 8.9k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (149 papers), Pharmaceutical Economics and Policy (139 papers), Biosimilars and Bioanalytical Methods (65 papers), Pharmaceutical studies and practices (41 papers), Pharmaceutical Practices and Patient Outcomes (21 papers), Intellectual Property and Patents (19 papers), Pneumonia and Respiratory Infections (14 papers) and Pharmaceutical industry and healthcare (12 papers). The work is most often cited by research in Economics and Econometrics (3.0k citations), Geriatrics and Gerontology (324 citations), Immunology (1.5k citations), Reproductive Medicine (502 citations) and Applied Microbiology and Biotechnology (109 citations). Steven Simoens has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Isabelle Huys, Arnold G. Vulto, Pieter Dylst, Minne Casteels, Lone Hummelshøj, Antonio Giuffrida, David Cassiman, Mélanie Bourassa Forcier, Paul Declerck and Eline Picavet. Their work appears in journals such as Frontiers in Pharmacology, Value in Health, Orphanet Journal of Rare Diseases, Applied Health Economics and Health Policy and BioDrugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.